Preventing coronary artery disease by lowering cholesterol levels. Fifty years from bench to bedside

Daniel Steinberg, Antonio Gotto

Research output: Contribution to journalArticle

144 Scopus citations

Abstract

In the more than 50 years since the founding of the National Heart, Lung, and Blood Institute and the American Heart Association, medical science has moved from an era in which hypercholesterolemia, as it is now-defined, was not believed to be abnormal to one in which controlling hypercholesterolemia is known to reduce not only coronary artery disease morbidity and mortality but also total mortality. While the efforts and successes of many researchers involved in this evolution are impressive, atherosclerosis is still a major cause of death and disability in many developed nations, mostly in the form of myocardial infarction and stroke, and is an increasing cause of morbidity and mortality in developing nations. Many questions about the detailed pathogenesis of the disease remain. Elucidating the roles of high-density lipoprotein, other lipoproteins, and homocysteine, as well as the roles of cytokines and growth factors, will permit better understanding and treatment of atherosclerosis. With continuing support for research and encouragement of physicians and patients to follow recommended preventive regimens, further progress can be made against this major cause of death.

Original languageEnglish (US)
Pages (from-to)2043-2050
Number of pages8
JournalJournal of the American Medical Association
Volume282
Issue number21
DOIs
StatePublished - Dec 1 1999

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Preventing coronary artery disease by lowering cholesterol levels. Fifty years from bench to bedside'. Together they form a unique fingerprint.

Cite this